|
Lecturer
Mahidol University, Thailand
Email: Wanwisa.dej@mahidol.ac.th
VALIDATE Role:
Network Associate
Research Keywords:
TB, Human Immune Responses, Antibody
Biography:
Dr. Wanwisa graduated her joint PhD in Immunology from Mahidol University (Thailand) and University of Oxford. After completing her PhD, Dr. Wanwisa accepted a position as research fellow at Imperial College London before returning to University of Oxford. Her research primarily focuses on T cell and antibody responses to flaviviruses, particularly dengue and Zika to inform the next generation vaccine design as well as to understanding the pathogenesis of severe dengue disease. Over the past year when COVID-19 emerged, she has pivoted her research to SARS-CoV-2 and diverted her skills and knowledge to study immune responses against SARS-CoV-2. She is recently appointed as a research lecturer at Mahidol University, Thailand. Her current research focuses on the immune responses to other emerging diseases such as tuberculosis.
Related Websites:
LinkedIn
Key Publications:
- Chansaengpetch S, Kaewlai R, Virojskulchai T, Jaroonpipatkul A, Chierakul N, Muangman N, Tongdee T, Tanomkiat W, Dissaneevate K, Bunman S, Ruangchira-Urai R, Dejnirattisai W, Dumavibhat N. Multidiscip Respir Med. 2024. Characteristics of culture-negative subclinical pulmonary tuberculosis: a single-center observation.
- Nutalai, R. and Dejnirattisai, W. et al. Cell. 2022. Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.
- Dejnirattisai, W. et al. Cell. 2022. Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.
- Dejnirattisai, W. et al. Lancet. 2021. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
- Dejnirattisai, W. et al. Cell Host Microbe. 2021. The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants.
- Dejnirattisai, W. et al. Cell. 2021. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
- Dejnirattisai, W. et al. Cell. 2021. Antibody evasion by the P.1 strain of SARS-CoV-2.
- Dejnirattisai, W. et al. Cell. 2021. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.
- Dejnirattisai, W. et al. Nat Commun. 2021. Flavivirus maturation leads to the formation of an occupied lipid pocket in the surface glycoproteins.
- Dejnirattisai, W. et al. Cell. 2021. Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.
|
